Skip to main content
. 2023 Apr 13;6(4):e238203. doi: 10.1001/jamanetworkopen.2023.8203

Table. Descriptive Statistics of Study Cohort per Month.

Characterisic Study year and montha
2021 2022
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
No. of cases 1140 3760 3820 3520 5720 22 400 35 710 4830 4180 12 200 23 890 13 250 13 170 5140 11 760 10 890 7780 11 980
Sex
Men 482 (42) 1541 (41) 1574 (41) 1480 (42) 2338 (41) 8707 (39) 13 392 (38) 1846 (38) 1571 (38) 4428 (36) 8684 (36) 4960 (37) 4880 (37) 1886 (37) 4388 (37) 3979 (37) 2934 (38) 4412 (37)
Women 658 (58) 2219 (59) 2246 (59) 2040 (58) 3382 (59) 13 693 (61) 22 318 (63) 2984 (62) 2609 (62) 7772 (64) 15 206 (64) 8290 (63) 8290 (63) 3245 (63) 7372 (63) 6911 (64) 4846 (62) 7568 (63)
Age, mean (SD) 43 (21) 43 (22) 44 (22) 46 (23) 43 (22) 41 (21) 42 (21) 46 (22) 46 (21) 48 (20) 50 (20) 50 (20) 51 (20) 51 (20) 54 (20) 57 (20) 56 (20) 56 (20)
Race
Asian 42 (4) 89 (2) 85 (2) 90 (3) 166 (3) 696 (3) 1574 (4) 220 (5) 225 (5) 591 (5) 1297 (5) 795 (6) 720 (5) 280 (5) 527 (4) 481 (4) 311 (4) 433 (4)
Black 120 (11) 385 (10) 293 (8) 184 (5) 317 (6) 1887 (8) 3263 (9) 265 (5) 174 (4) 496 (4) 985 (4) 591 (4) 674 (5) 307 (6) 533 (5) 462 (4) 382 (5) 602 (5)
White 879 (77) 2850 (76) 3060 (80) 2940 (84) 4658 (81) 16 862 (75) 25 519 (71) 3881 (80) 3489 (83) 10 318 (85) 19 776 (83) 10 842 (82) 10 682 (81) 4120 (80) 9794 (83) 9213 (85) 6403 (82) 9872 (82)
Other or unknownb 113 (10) 427 (11) 426 (11) 325 (9) 588 (10) 2975 (13) 5358 (15) 438 (9) 283 (7) 895 (7) 1852 (8) 1046 (8) 1122 (9) 451 (9) 904 (8) 733 (7) 674 (9) 1074 (9)
Unvaccinated 548 (487) 1786 (48) 1770 (46) 1473 (42) 2506 (44) 6906 (31) 8831 (25) 1014 (21) 513 (12) 1243 (10) 2368 (10) 1267 (10) 1238 (9) 560 (11) 1198 (10) 1015 (9) 777 (10) 1132 (9)
≥2 Vaccines 561 (49) 1866 (50) 1951 (51) 1923 (55) 2971 (52) 14 547 (65) 25 395 (71) 3570 (74) 3526 (84) 10 645 (87) 20 784 (87) 11 564 (87) 11 557 (88) 4449 (87) 10 213 (87) 9533 (88) 6762 (87) 10 454 (87)
Prior infection 44 (4) 75 (2) 58 (2) 60 (2) 84 (1) 1049 (5) 2262 (6) 299 (6) 169 (4) 537 (4) 1249 (5) 914 (7) 1131 (9) 560 (11) 1178 (10) 1114 (10) 1079 (14) 2588 (22)
Corticosteroid treatment 75 (7) 245 (7) 258 (7) 243 (7) 348 (6) 900 (4) 1281 (4) 288 (6) 210 (5) 432 (4) 783 (3) 453 (3) 528 (4) 204 (4) 494 (4) 556 (5) 398 (5) 704 (6)
Paxlovid 0 0 0 0 0 1 (0.004) 28 (0.08) 95 (2) 511 (12) 3041 (25) 6582 (28) 3738 (28) 4018 (31) 1564 (30) 3503 (30) 3095 (28) 2282 (29) 3977 (33)
Remedsivir 45 (4) 144 (4) 162 (4) 133 (4) 212 (4) 506 (2) 713 (2) 134 (3) 86 (2) 212 (2) 370 (2) 215 (2) 275 (2) 139 (3) 258 (2) 335 (3) 355 (5) 684 (6)
Elixhauser comorbidity index, mean (SD) 1.54 (2.3) 1.52 (2.3) 1.63 (2.3) 1.74 (2.4) 1.67 (2.3) 1.53 (2.2) 1.72 (2.4) 2.04 (2.8) 1.85 (2.5) 1.93 (2.4) 1.98 (2.4) 2.07 (2.5) 2.32 (2.6) 2.46 (2.7) 2.50 (2.7) 2.67 (2.8) 2.77 (3.0) 2.93 (3.0)
Hospitalization 87 (8) 209 (6) 223 (6) 195 (6) 269 (5) 661 (3) 929 (3) 339 (7) 180 (4) 323 (3) 590 (2) 358 (3) 479 (4) 218 (4) 442 (4) 536 (5) 413 (5) 808 (7)
Mortality 8 (0.70) 16 (0.43) 23 (0.60) 26 (0.73) 51 (0.89) 78 (0.35) 132 (0.37) 30 (0.62) 25 (0.60) 27 (0.22) 48 (0.20) 24 (0.18) 30 (0.23) 17 (0.33) 44 (0.37) 48 (0.44) 43 (0.55) 54 (0.45)
a

Unless otherwise indicated, data are expressed as No. (%) of cases. Numbers are obfuscated (thus sums may not add up to true marginal totals), and percentages are rounded.

b

Other includes American Indian or Alaska Native, Arab, Native Hawaiian or other Pacific Islander, multiple races, or other. Unknown refers to unknown or declined to answer. Race was self-identified by patients within their electronic health record.